Connect with us
[the_ad id="89560"]

Health

Hundreds of doctors resign from British Medical Association over its support for puberty blockers

Published

8 minute read

From LifeSiteNews

By Jonathon Van Maren

Hundreds of U.K. doctors are resigning from the British Medical Association over its opposition to a ban on puberty blockers for kids, accusing the union of ignoring evidence-based medicine and failing to represent its members’ views.

According to reports in The Times and The Telegraph, hundreds of doctors are not only going public to express their anger with the British Medical Associations’ decision to reject the Cass Review’s findings on the dangers of puberty blockers – and many are resigning.  

According to The Telegraph: “Doctors with decades of experience have resigned from the British Medical Association because of the union’s opposition to the Cass review.”  

As I reported earlier in this space, on August 1 the British Medical Association – the U.K. doctor’s union – called on the government to lift the ban on puberty blockers for minors and called for a pause on the implementation of the National Health Service’s Cass Review. 

Initially, 1,000 senior physicians from across the U.K. responded by publishing an open letter to chairman of the BMA, Professor Philip Banfield; that number is now up to 1,400, with 900 of those being BMA members. Among their accusations is that the 69-member council passed their policy at a “secretive and opaque” meeting.  

READ: Texas forbids changing sex on driver’s licenses, state IDs for ‘gender identity’ 

“We write as doctors to say, ‘not in my name,’” the letter read. “We are extremely disappointed that the BMA council had passed a motion to conduct a ‘critique’ of the Cass Review and to lobby to oppose its recommendations … It does not reflect the views of the wider membership, whose opinion you did not seek. We understand that no information will be released on the voting figures and how council members voted. That is a failure of accountability to members and is simply not acceptable.”  

The letter further stated that the Cass Review “is the most comprehensive review into healthcare for children with gender related distress ever conducted” and urged the BMA to “abandon its pointless exercise” of attacking and opposing the recommendations. 

“By lobbying against the best evidence we have, the BMA is going against the principles of evidence-based medicine and against ethical practice,” the doctors wrote, in an almost unprecedented broadside against their own union in protest of the BMA’s brazen transgender activism. 

As first reported by The Times, comments made beneath that open letter “reveal many doctors have torn up their membership cards in response to the union’s stance on the review.” One commenter stated: “On the basis of the BMA’s outrageous stance on the superbly researched and written Cass Report, which has my full support and endorsement, I have decided to leave the BMA having been a member for 50 years since I qualified as a doctor. Increasingly, they not only fail to represent my views, they display no respect for the very premise and ethos inherent in being a medical professional.” 

Another doctor wrote: “As a union, primarily, it is the role of the BMA to represent its members, and not to drive clinical opinion, especially in specialist areas. I am considering resigning after membership of 42 years.” A third stated: “I left the BMA partly because of this sort of behaviour on the part of the leadership, having been a member for some thirty years.” Jacky Davis, a consultant radiologist and council member, told The Times: 

This minority has voted to block the implementation of Cass, an evidence-based review which took four years to put together. They have no evidence for their opposition. The Cass review is not a matter for a trade union. It is not our business as a union to be doing a critique of the Cass review. It is a waste of time and resources.

GB News also reported on the exodus, reporting that: “Critics slammed the decision as not representing the views of all members, critiquing the BMA’s ‘abysmal’ leadership which was becoming ‘increasingly bonkers and ideologically captured.’” And according to the Daily Mail: “One signatory called for a ‘vote of no confidence in BMA leadership’ and another commenting that ‘activists appear to have been allowed to take over.’” 

What is so extraordinary about this is that LGBT activists have achieved phenomenal success by infiltrating and taking over organizations, and then imposing their agenda from the top-down. Once LGBT activists are in a position to pass policies, control votes, and even censor publications, their agenda is assured. This has been incredibly effective for decades. 

In this instance, however, the ideologically captured British Medical Association is facing a full-scale revolt from its own members, and its credibility is taking a severe hit. Even the press coverage of their move, which would have been laudatory only a few years ago, is almost universally negative.  

The BMA is still committed to its agenda – but its grip on the narrative has been broken, and it seems unlikely that the union will be able to reestablish it.  

Featured Image

Jonathon’s writings have been translated into more than six languages and in addition to LifeSiteNews, has been published in the National PostNational ReviewFirst Things, The Federalist, The American Conservative, The Stream, the Jewish Independent, the Hamilton SpectatorReformed Perspective Magazine, and LifeNews, among others. He is a contributing editor to The European Conservative.

His insights have been featured on CTV, Global News, and the CBC, as well as over twenty radio stations. He regularly speaks on a variety of social issues at universities, high schools, churches, and other functions in Canada, the United States, and Europe.

He is the author of The Culture WarSeeing is Believing: Why Our Culture Must Face the Victims of AbortionPatriots: The Untold Story of Ireland’s Pro-Life MovementPrairie Lion: The Life and Times of Ted Byfield, and co-author of A Guide to Discussing Assisted Suicide with Blaise Alleyne.

Jonathon serves as the communications director for the Canadian Centre for Bio-Ethical Reform.

Addictions

There’s No Such Thing as a “Safer Supply” of Drugs

Published on

By Adam Zivo

Sweden, the U.K., and Canada all experimented with providing opioids to addicts. The results were disastrous.

[This article was originally published in City Journal, a public policy magazine and website published by the Manhattan Institute for Policy Research. We encourage our readers to subscribe to them for high-quality analysis on urban issues]

Last August, Denver’s city council passed a proclamation endorsing radical “harm reduction” strategies to address the drug crisis. Among these was “safer supply,” the idea that the government should give drug users their drug of choice, for free. Safer supply is a popular idea among drug-reform activists. But other countries have already tested this experiment and seen disastrous results, including more addiction, crime, and overdose deaths. It would be foolish to follow their example.

The safer-supply movement maintains that drug-related overdoses, infections, and deaths are driven by the unpredictability of the black market, where drugs are inconsistently dosed and often adulterated with other toxic substances. With ultra-potent opioids like fentanyl, even minor dosing errors can prove fatal. Drug contaminants, which dealers use to provide a stronger high at a lower cost, can be just as deadly and potentially disfiguring.

Because of this, harm-reduction activists sometimes argue that governments should provide a free supply of unadulterated, “safe” drugs to get users to abandon the dangerous street supply. Or they say that such drugs should be sold in a controlled manner, like alcohol or cannabis—an endorsement of partial or total drug legalization.

But “safe” is a relative term: the drugs championed by these activists include pharmaceutical-grade fentanyl, hydromorphone (an opioid as potent as heroin), and prescription meth. Though less risky than their illicit alternatives, these drugs are still profoundly dangerous.

The theory behind safer supply is not entirely unreasonable, but in every country that has tried it, implementation has led to increased suffering and addiction. In Europe, only Sweden and the U.K. have tested safer supply, both in the 1960s. The Swedish model gave more than 100 addicts nearly unlimited access through their doctors to prescriptions for morphine and amphetamines, with no expectations of supervised consumption. Recipients mostly sold their free drugs on the black market, often through a network of “satellite patients” (addicts who purchased prescribed drugs). This led to an explosion of addiction and public disorder.

Most doctors quickly abandoned the experiment, and it was shut down after just two years and several high-profile overdose deaths, including that of a 17-year-old girl. Media coverage portrayed safer supply as a generational medical scandal and noted that the British, after experiencing similar problems, also abandoned their experiment.

While the U.S. has never formally adopted a safer-supply policy, it experienced something functionally similar during the OxyContin crisis of the 2000s. At the time, access to the powerful opioid was virtually unrestricted in many parts of North America. Addicts turned to pharmacies for an easy fix and often sold or traded their extra pills for a quick buck. Unscrupulous “pill mills” handed out prescriptions like candy, flooding communities with OxyContin and similar narcotics. The result was a devastating opioid epidemic—one that rages to this day, at a cumulative cost of hundreds of thousands of American lives. Canada was similarly affected.

The OxyContin crisis explains why many experienced addiction experts were aghast when Canada greatly expanded access to safer supply in 2020, following a four-year pilot project. They worried that the mistakes of the recent past were being made all over again, and that the recently vanquished pill mills had returned under the cloak of “harm reduction.”

Subscribe for free to get BTN’s latest news and analysis – or donate to our investigative journalism fund.

Most Canadian safer-supply prescribers dispense large quantities of hydromorphone with little to no supervised consumption. Patients can receive up to 40 eight-milligram pills per day—despite the fact that just two or three are enough to cause an overdose in someone without opioid tolerance. Some prescribers also provide supplementary fentanyl, oxycodone, or stimulants.

Unfortunately, many safer-supply patients sell or trade a significant portion of these drugs—primarily hydromorphone—in order to purchase more potent illicit substances, such as street fentanyl.

The problems with safer supply entered Canada’s consciousness in mid-2023, through an investigative report I wrote for the National Post. I interviewed 14 addiction physicians from across the country, who testified that safer-supply diversion is ubiquitous; that the street price of hydromorphone collapsed by up to 95 percent in communities where safer supply is available; that youth are consuming and becoming addicted to diverted safer-supply drugs; and that organized crime traffics these drugs.

Facing pushback, I interviewed former drug users, who estimated that roughly 80 percent of the safer-supply drugs flowing through their social circles was getting diverted. I documented dozens of examples of safer-supply trafficking online, representing tens of thousands of pills. I spoke with youth who had developed addictions from diverted safer supply and adults who had purchased thousands of such pills.

After months of public queries, the police department of London, Ontario—where safer supply was first piloted—revealed last summer that annual hydromorphone seizures rose over 3,000 percent between 2019 and 2023. The department later held a press conference warning that gangs clearly traffic safer supply. The police departments of two nearby midsize cities also saw their post-2019 hydromorphone seizures increase more than 1,000 percent.

The Canadian government quietly dropped its support for safer supply last year, cutting funding for many of its pilot programs. The province of British Columbia (the nexus of the harm-reduction movement) finally pulled back support last month, after a leaked presentation confirmed that safer-supply drugs are getting sold internationally and that the government is investigating 60 pharmacies for paying kickbacks to safer-supply patients. For now, all safer-supply drugs dispensed within the province must be consumed under supervision.

Harm-reduction activists have insisted that no hard evidence exists of widespread diversion of safer-supply drugs, but this is only because they refuse to study the issue. Most “studies” supporting safer supply are produced by ideologically driven activist-scholars, who tend to interview a small number of program enrollees. These activists also reject attempts to track diversion as “stigmatizing.”

The experiences of Sweden, the United Kingdom, and Canada offer a clear warning: safer supply is a reliably harmful policy. The outcomes speak for themselves—rising addiction, diversion, and little evidence of long-term benefit.

As the debate unfolds in the United States, policymakers would do well to learn from these failures. Americans should not be made to endure the consequences of a policy already discredited abroad simply because progressive leaders choose to ignore the record. The question now is whether we will repeat others’ mistakes—or chart a more responsible course.

Our content is always free –

but if you want to help us commission more high-quality journalism,

consider getting a voluntary paid subscription.

Continue Reading

Health

RFK Jr. says ‘everything is going to change’ with CDC vaccine policy in Michael Knowles interview

Published on

From LifeSiteNews

By Doug Mainwaring

When Michael Knowles asked new Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. if anything will change regarding the public’s justifiable concern with the growth of vaccines, Kennedy quickly shot back, “Everything is going to change.”

Kennedy pointed to the Centers for Disease Control’s current flawed VAERS (Vaccine Adverse Event Reporting System) online mechanism.

By way of example, he said, “None of the vaccines that are given during the first six months of life have ever been tested for autism. The only one was the DTP vaccine. And that one study that was done, according to the Institute of Medicine, the National Academy of Sciences, found that there was a link.”

But “They threw out that study because it was based upon CDC’s surveillance system, VAERS, and they said that system is no good.”

“That begs the question, why doesn’t CDC have a functional surveillance system?” he asked. “We’re gonna make sure they do.”

“They don’t do pre-licensing safety testing for vaccines” he continued. “They’re the only product that’s exempt. So what they say is, if there are injuries, we’ll capture them afterward.”

However, “they have a system that doesn’t capture them. In fact, CDC’s own study of its own system said it captures fewer than 1% of vaccine injuries,” Kennedy said. “It’s worthless, and everybody agrees it’s worthless.”

“Why have we gone for 39 years and nobody’s fixed it?” he wondered, promising, “We’re gonna fix it.”

“We have DOGE (which) knows how to manage data. We’re going to be able to get into these databases and give answers to the American public,” Kennedy predicted.

“We’re going to do replication of all of our studies, which CDC has never done. We’re going to publish our peer review, which CDC has never done,” Kennedy vowed. “So people are going to have real answers for the first time.”

The new HHS head also discussed more broadly his mission after taking over the department’s helm, the mess created by the Biden administration, his job’s challenges, and recent developments thanks to DOGE.

“HHS is a $1.9 trillion agency. It’s the biggest agency in the government. And during the Biden administration, President Biden increased its budget by 38% and increased the workforce by 17%.”

“And by every metric by which we measure public health, health accelerated its decline.”

“When I came to HHS, what I found was a sprawling bureaucracy,” with functional duplication of departments, rampant redundancy and overstaffing, with various sub-agencies often acting in a territorial, self-protecting manner rather than a synergistic one.

“Perverse incentives” sometimes drive employee’s work,” he noted.

Despite his short tenure at HHS, with the help of DOGE, Kennedy has already released 20,000 “bureaucrats” from the department’s ranks.

“We’re going from 82,000 personnel to 62,000,” said Kennedy, carefully pointing out, “We’re keeping the scientists and frontline providers.”

Kennedy said that it has been really hard to fight against the problems at HHS and NIH over the last 40 years from “the outside.”

But “now I’m on the inside,” he declared. “This is the purpose of my life. It’s what I’m going to do over the next four years.”

He concluded:

President Trump promised to return the American dream to Americans.

A healthy person has a thousand dreams. A sick person only has one.

Continue Reading

Trending

X